Who is eligible for the FreeStyle Libre 2 system?
The FreeStyle Libre 2 system can safely and successfully replace routine self‐monitoring of blood glucose (SMBG)v in diabetes patients using Multiple daily injection (MDI) or Continuous Subcutaneous Insulin Infusions (CSII).
V. Finger pricks are required if glucose readings and alarms don't match symptoms or expectations.
The "Yes" link below will take you to a website other than Abbott Laboratories. Links to other websites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the content of such websites or any link contained in such websites. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement by Abbott Laboratories of the site.
Do you want to leave this page?
If you're a healthcare professional located in a different country, please select your country's website from the list of our global sites or contact your local Abbott representative for correct information about the products available in your country.
If you're not a healthcare profressional, click here to go to the FreeStyle Libre consumer website for the UK.
Stay connected